The giants divide the food and medicine e-commerce blue sea

With the help of the purchase model to ignite the new E-Commerce model, in just three years has grown into a “third pole” that threatens Tmall and JD. Recently, it has been reported that many people have been eyeing the medical E-Commerce business that is regarded as the blue ocean. For this E-Commerce platform that has repeatedly tried to wash the “low price and low quality” stigma, there is probably no small change in this move.

According to a recent report by China Entrepreneur, the company has launched a health channel on its App. The current sub-categories include medical family planning, refined Chinese herbal medicines and contact lenses. In addition, people who claim to have a large number of employees have begun to invite investment, and companies with Internet drug trading certificates are invited to enter the health channel of their platform. The report also shows that many people have already dig a lot of talents in the medical industry, and are also hiring commodity management specialists in the direction of medicine. Various signs of water testing indicate that the company is actively paving the way for incoming medical E-Commerce.

According to Jingdong’s “China Drug Retail Market Consumption Trend Report” released in May this year, the size of the physical pharmacy market has increased from 187 billion to 269 billion in the past five years, and the online pharmacy market has increased from 1.2 billion to 6.1 billion. The growth rate has ranged from 35.56% to 58.33% in five years. Compared with the compound growth rate of retail pharmacies in the past five years, only 9.52%, the online pharmaceutical retail market can be said to have a very rapid growth momentum, which is bound to become a battleground for pharmaceutical companies to develop sales channels.

As an early-stage integrated medical E-Commerce company, today’s medicine has become an indispensable business segment for Tmall and JD. Ali Health Financial Report shows that the GMV (total trading volume) of Tmall Medical Museum in FY 2018 (April 2017~March 2018) is close to 40 billion yuan.

In addition to these two comprehensive E-Commerce platforms that have taken the lead, Suning, Vipshop and other integrated E-Commerce platforms have also shown strong interest in medical E-Commerce. After obtaining the “Internet Drug Information Service Qualification Certificate” in 2016, Suning Tesco launched the “Suning Tesco Medicine Museum” in the same year. Vipshop will pass the subscription of 2.28 million yuan in 2017 and obtain 100% shares of Guangzhou Haoxin Pharmaceutical Chain. In addition, Vipshop will also draw up the revision, Kang Enbei, Swisse and other pharmaceutical brands to settle in, but as of now, the products for sale are basically based on health products.

As a comprehensive E-Commerce company, it is probably the problem of counterfeit goods that has been criticized for its many medical E-Commerce companies. In fact, after being “lifted” into the Nasdaq Stock Exchange by the “five-ring” consumers, it is clear that more and more attention has been paid to public opinion on the proliferation of counterfeit goods on the platform and the low quality of products, and some measures have been launched. .

In August of this year, a lot of “doubles action” staged explanations were released. The data shows that from August 2 to August 9, the platform has forcibly closed 1,128 stores, and nearly 4.3 million pieces of goods were removed, and more than 450,000 suspected counterfeit goods were blocked in batches. While promulgating the effectiveness of “counterfeiting”, the company has also actively promoted the selection of Netease’s strict selection, Xiaomi and Gome brand merchants, and intended to rewrite the stereotype of the platform “cheap and no good goods”.

However, in nature, pharmaceutical products are different from daily necessities such as laundry detergents and paper towels. The safety and quality are higher than everything. For those who have entered the medical E-Commerce business, some netizens will vomit to say that they are all brave. In addition, in the current comprehensive E-Commerce platform has entered the medical E-Commerce, the platform must be competitive in the pharmaceutical sector, in addition to price, supply chain and logistics will be inseparable. At present, Ali and Jingdong are all committed to strengthening the offline retail distribution of medicines, relying on their own O2O platform to infiltrate pharmaceutical distribution into the community scene, and the main low-cost, high-purchase spells do not necessarily have much chance of winning.